The importance of central sensitization for clinical trials of Disease Modifying Osteoarthritis drugs (DMOADs)
(2025)
Journal Article
Walsh, D. A., & McWilliams, D. F. (2025). The importance of central sensitization for clinical trials of Disease Modifying Osteoarthritis drugs (DMOADs). Osteoarthritis Imaging, 100261. https://doi.org/10.1016/j.ostima.2025.100261
Osteoarthritis (OA) pain is associated with structural changes in the joint, which are usually quantified by imaging techniques. It is anticipated that structural disease modifying OA drugs (DMOADs) would reduce the burden of OA pain. However, nocice... Read More about The importance of central sensitization for clinical trials of Disease Modifying Osteoarthritis drugs (DMOADs).